Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto

Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto

Submitted by admin on January 7, 2020 - 10:53am
Source: 
Xconomy
News Tags: 
Amira Pharmaceuticals
Bristol-Myers Squibb
Celgene
PharmAkea
Galecto Biotech
fibrotic disease
Headline: 
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto
snippet: 

When a group of scientists from Amira Pharmaceuticals wanted to start a new biotech after the company’s 2011 acquisition by Bristol-Myers Squibb, Celgene provided seed funding.

Do Not Allow Advertisers to Use My Personal information